title: Pharmacology of PEG-asparaginase in childhood acute lymphoblastic leukemia (ALL).
authors.forename: Joao Paulo Vieira
authors.initials: JP
authors.lastname: Pinheiro
authors.forename: Claudia
authors.initials: C
authors.lastname: Lanvers
authors.forename: Gudrun
authors.initials: G
authors.lastname: Würthwein
authors.forename: Joachim
authors.initials: J
authors.lastname: Boos
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage* / Q000737:chemistry; D001216:Asparagine / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli; D006801:Humans; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000737:chemistry; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D001216:Asparagine; D001215:Asparaginase